Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 78
Filtrar
1.
Front Vet Sci ; 10: 1045276, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-36876011

RESUMEN

In response to the need to manage Antimicrobial Resistance (AMR), countries have produced National Action Plans (NAPs), which require detailed information of the AMR situation in all sectors. Considering the limited information that is publicly available for an analysis of the AMR situation in animal production, the FAO Regional Office for Latin America and the Caribbean (FAO RLC) developed the "FAO tool for a situation analysis of AMR risks in the food and agriculture sectors." The objective of this paper is to present the methodology developed for a qualitative evaluation of the risk factors of AMR toward animal and human health, based on terrestrial and aquatic production systems and their associated national public and private mitigation measures. The tool was developed reflecting the AMR epidemiological model and the guidelines to conduct a risk analysis of AMR from the Codex Alimentarius and WOAH. Applied in four stages of progressive development, the objective of the tool is to provide a qualitative and systematic assessment of the risks of AMR from animal production systems, to animal and human health, and to identify gaps in cross cutting factors in AMR management. The tool consists of three instruments: (i) a survey to collect data for a situation analysis of AMR risks; (ii) a methodological procedure for the analysis of the information obtained; (iii) instructions for the preparation of a national roadmap for the containment of AMR at a national level. Based on the results from the information analysis, a roadmap is prepared by guiding and prioritizing the needs and sectoral actions for the containment of AMR under an intersectoral, multidisciplinary and collaborative approach, and according to country priorities and resources. The tool helps to determine, visualize and prioritize the risk factors and challenges that contribute to AMR from the animal production sector and that need to be addressed to manage AMR.

2.
JCO Glob Oncol ; 8: e2200165, 2022 11.
Artículo en Inglés | MEDLINE | ID: mdl-36351213

RESUMEN

PURPOSE: Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoma subtype. The purpose of this study was to evaluate the clinical features, prognostic factors, and results of DLBCL that was treated in the cancer centers of the public health system in Chile and compare cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) with rituximab with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP). PATIENTS AND METHODS: Patients age > 15 years who were treated in 18 cancer centers in the country between 2001 and 2017 were included. The Kaplan-Meier method was used to calculate overall survival (OS), and Cox proportional hazard regression modeling was used to evaluate the effect of the addition of rituximab to CHOP on OS. RESULTS: A total of 1,807 patients were evaluated. The median age at diagnosis was 62 (range, 15-95) years, with a female predominance (53%). Half of the patients were age ≥ 60 years. Serology for HIV infection was positive in 5% of cases (96 cases). International Prognostic Index scores were available for 90% of patients, of which 45% had low-risk, 25% low-intermediate-risk, 18% high-intermediate-risk, and 11% high-risk scores. CHOP was administered to 986 patients (55%; median follow-up, 13.2 years) and R-CHOP to 821 patients (45%; median follow-up, 8.4 years). R-CHOP was associated with superior OS compared with CHOP (5-year 66% v 48%, and 10-year 53% v 35%; P < .001). CONCLUSION: Rituximab improved the survival of patients with DLBCL diagnosed and treated in Chile. The benefit was sustained over time, with curative rates of > 50%. This intervention shows that the inclusion of this biological drug justified the expenses incurred by the Ministry of Health in the National Lymphoma Protocols in Chile.


Asunto(s)
Infecciones por VIH , Linfoma de Células B Grandes Difuso , Humanos , Femenino , Adolescente , Adulto Joven , Adulto , Persona de Mediana Edad , Anciano , Anciano de 80 o más Años , Masculino , Rituximab/uso terapéutico , Vincristina/uso terapéutico , Prednisona/efectos adversos , Salud Pública , Infecciones por VIH/inducido químicamente , Infecciones por VIH/tratamiento farmacológico , Chile/epidemiología , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Linfoma de Células B Grandes Difuso/tratamiento farmacológico , Linfoma de Células B Grandes Difuso/patología , Ciclofosfamida/uso terapéutico , Doxorrubicina/efectos adversos
3.
Rev Med Chil ; 150(3): 331-338, 2022 Mar.
Artículo en Español | MEDLINE | ID: mdl-36156718

RESUMEN

BACKGROUND: The incorporation of novel drugs, such as proteasome inhibitors and immunomodulators, improved considerably the survival of patients with multiple myeloma. AIM: To evaluate the effect on survival of proteasome inhibitors and immunomodulators in patients with multiple myeloma in two national hospitals. MATERIAL AND METHODS: Review of clinical records from two hospitals of Santiago. Epidemiological, clinical, laboratory and therapeutic data was obtained from 144 patients with multiple myeloma diagnosed between 2002 and 2016. RESULTS: Information was retrieved from 78 patients at one center and from 66 at the other center. The mean age at diagnosis was 58 and 62 years, the proportion of males was 53% and 52%, and presentation at stage III was 34% and 46%, respectively. The use of novel drugs, mainly bortezomib, was 90% in one of the centers and 3% in the other one. The use of autologous stem-cell transplantation was 47% and 3% respectively. The median overall survival of patients from the centers with and without access to novel drugs was 117 and 71 months respectively (p < 0.05). The five-year overall survival was 93 and 43% respectively (p < 0.05). CONCLUSIONS: The use of novel drugs, especially bortezomib, and autologous stem-cell transplantation significantly improved the survival of multiple myeloma patients treated in national hospitals. It is necessary to include them as a first line treatment.


Asunto(s)
Trasplante de Células Madre Hematopoyéticas , Mieloma Múltiple , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Bortezomib/uso terapéutico , Chile/epidemiología , Humanos , Masculino , Mieloma Múltiple/diagnóstico , Inhibidores de Proteasoma/uso terapéutico , Trasplante Autólogo
4.
Rev. méd. Chile ; 150(3): 331-338, mar. 2022. tab, graf
Artículo en Español | LILACS | ID: biblio-1409806

RESUMEN

BACKGROUND: The incorporation of novel drugs, such as proteasome inhibitors and immunomodulators, improved considerably the survival of patients with multiple myeloma. Aim: To evaluate the effect on survival of proteasome inhibitors and immunomodulators in patients with multiple myeloma in two national hospitals. MATERIAL AND METHODS: Review of clinical records from two hospitals of Santiago. Epidemiological, clinical, laboratory and therapeutic data was obtained from 144 patients with multiple myeloma diagnosed between 2002 and 2016. Results: Information was retrieved from 78 patients at one center and from 66 at the other center. The mean age at diagnosis was 58 and 62 years, the proportion of males was 53% and 52%, and presentation at stage III was 34% and 46%, respectively. The use of novel drugs, mainly bortezomib, was 90% in one of the centers and 3% in the other one. The use of autologous stem-cell transplantation was 47% and 3% respectively. The median overall survival of patients from the centers with and without access to novel drugs was 117 and 71 months respectively (p < 0.05). The five-year overall survival was 93 and 43% respectively (p < 0.05). CONCLUSIONS: The use of novel drugs, especially bortezomib, and autologous stem-cell transplantation significantly improved the survival of multiple myeloma patients treated in national hospitals. It is necessary to include them as a first line treatment.


Asunto(s)
Humanos , Masculino , Trasplante de Células Madre Hematopoyéticas , Mieloma Múltiple/diagnóstico , Trasplante Autólogo , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Chile/epidemiología , Inhibidores de Proteasoma/uso terapéutico , Bortezomib/uso terapéutico
5.
Acta méd. peru ; 38(3)jul. 2021.
Artículo en Español | LILACS-Express | LILACS | ID: biblio-1505491

RESUMEN

Objetivos : Explicar el rol del Estado Peruano relacionado a los procesos participativos de los diversos actores que influyen en la regulación concerniente a la autorización de ensayos clínicos (EC). Metodología : Se presenta parte del estudio de caso correspondiente a una tesis de doctor llevada a cabo entre los años 2015 y 2017. Se utilizó información documental y se realizaron 14 entrevistas semiestructuradas a informantes claves. También se sistematizaron experiencias relacionadas a la autorización e inspección de ensayos clínicos, así como la verificación de centros de investigación. Se contó también con la información pública disponible del Instituto Nacional de Salud del Perú. El análisis se realizó dentro de un marco epistemológico y hermenéutico con la aprobación del Comité de Ética de la Facultad de Medicina de San Fernando. Resultados : Los temas identificados fueron los siguientes: demora en los tiempos regulatorios que autorizan los ensayos, aumento de las no autorizaciones en un determinado lapso de 3 años, suspensión de las autorizaciones para ejecutar EC en niños, lo que llevó a una progresiva reducción de las solicitudes y por consiguiente de los ensayos clínicos desde el año 2009 en adelante. Conclusiones : En el estudio realizado, la regulación del Estado Peruano en cuanto a la autorización de EC se ha debilitado al reducir el ejercicio de ciudadanía en salud de los participantes y las fortalezas de algunos actores, particularmente la generación de competencias de los investigadores para desarrollar EC.


Objectives : To explain the role of the Peruvian Government related to participation of different stakeholders influencing regulations for authorizing clinical trials (CT). Methodology : We present part of a case study corresponding to a PhD thesis performed between 2015 and 2017. We used document information and 14 semi-structured interviews with key informants were performed. We also systematized experiences related to clinical trial authorization and inspection, as well as verification of investigation sites. We also had access to publicly available information from the Peruvian National Institute of Health. The analysis was performed within epistemological and hermeneutical frameworks, and it was approved by the Ethics Committee from San Fernando Public Medicine School. Results : Issues identified were as follows: Delay in regulatory times authorized for CTs; suspension of authorizations for performing CTs in children, which led to progressive reduction in requests and consequently to a reduction in CTs from 2009 on. Conclusions : According to this study, regulations by Peruvian authorities have weakened, since participants and some stakeholders are not able to exert their rights, particularly with respect to competence generation for researchers when trying to develop CTs.

6.
An. Fac. Med. (Perú) ; 82(2): 131-139, abr.-jun 2021. tab
Artículo en Español | LILACS-Express | LILACS | ID: biblio-1339085

RESUMEN

RESUMEN Objetivos. Determinar el nivel de conocimientos y prácticas sobre las medidas de prevención de las infecciones asociadas a la atención de salud (IAAS) y sus factores asociados en médicos residentes ingresantes 2018 de una universidad de Lima, Perú. Métodos. Estudio transversal en el cual se aplicó un cuestionario validado a 171 médicos residentes. Las variables estudiadas fueron edad, sexo, tiempo como profesional, capacitaciones previas, procedencia, tipo de universidad de procedencia, entre otras. Resultados. 52% de los participantes fueron de sexo femenino, el 49% tenía 2 o menos años de tiempo como profesional médico, el 49% provenía de una universidad del interior del país, solo el 34% ocupó una vacante cautiva y el 71,9% tuvo capacitaciones previas sobre medidas de prevención de IAAS. El 83% de los médicos residentes ingresantes estudiados mostró poco conocimiento sobre medidas de prevención de las IAAS mientras que el 68,4% mostró prácticas no adecuadas sobre medidas de prevención de las IAAS. El ingreso a una especialidad de medicina estuvo asociado a un menor riesgo de tener poco conocimiento (OR: 0,32, IC 95%: 0,11-0,93). El mayor tiempo como profesional se relacionó a un menor riesgo de tener prácticas inadecuadas (OR: 0,936, IC 95%: 0,89-0,99). Conclusiones. Existe un bajo nivel de conocimientos sobre medidas de prevención de IAAS y una elevada proporción de los residentes ingresantes 2018 tuvo prácticas no adecuadas sobre medidas de prevención de IAAS. Se observó que el tipo de especialidad fue un factor asociado al nivel de conocimientos y el tiempo de experiencia profesional fue un factor asociado al tipo de práctica.


ABSTRACT Objectives. To determine level of knowledge and practices on the measures of prevention of infections associated with health care (HAI) and factors associated with in incoming resident physicians 2018 of a university of Lima, Peru. Methods. A validated questionnaire was applied to 171 resident physicians in a cross-sectional study. Variables studied were age, sex, time as a professional, previous training, origin, type of university of origin, among others. Results. It was observed that 52% are female, 49% had 2 or less years as a medical professional, 49% came from a university in the interior of the country, only 34% occupied a captive vacancy and 71.9% had previous training on HAI prevention measures. 83% of the incoming resident physicians studied showed a low level of knowledge about HAI prevention measures while 68.4% of the incoming resident physicians studied showed inappropriate practices on HAI prevention measures. When performing the multivariate analysis, it showed that entering a medicine specialty was associated with a lower risk of having low level of knowledge (OR: 0.32, 95% CI: 0.11-0.93). The bivariate analysis showed that the longest time as a professional was related to lower risk of having inappropriate practices, this being confirmed when performing the multivariate analysis (OR: 0.936, 95% CI: 0.89-0.99). Conclusions. There is a low level of knowledge about HAI prevention measures and a high proportion with inappropriate practices in incoming residents 2018 on HAI prevention measures. It was observed that the type of specialty is a factor associated with the level of knowledge and the time of professional experience is a factor associated with the type of practice.

8.
Materials (Basel) ; 13(14)2020 Jul 17.
Artículo en Inglés | MEDLINE | ID: mdl-32709139

RESUMEN

In the forging industry, surface quality and surface treatments of dies are crucial parameters to extend their life. These components are usually machined by milling or by Electrical Discharge Machining (EDM), and the final surface roughness depends on the machining techniques and operational conditions used in its fabrication. After milling, a nitriding treatment is widely applied to extend its service life. Nevertheless, no scientific report that informs about nitriding after EDM has been found. Accordingly, this work focuses on the wear and friction behavior of pins made of brass and medium carbon steel sliding over AISI H13 discs, made by wire EDM in the conditions of finishing and roughing. The discs are plasma nitride, and their effect on the wear during pin-on-disc tests is evaluated. In this sense, the analysis of the surface damage for the different pins will help us to understand the service life and wear evolution of the forging dies. The results show that plasma nitride reduces the friction and prevents the degradation of the pin, independently of the material of the pin, when sliding over finishing and roughing EDM conditions.

9.
Materials (Basel) ; 13(3)2020 Jan 24.
Artículo en Inglés | MEDLINE | ID: mdl-31991699

RESUMEN

The objective of this work is to analyze the influence of the vibration-assisted turning process on the machinability of S235 carbon steel. During the experiments using this vibrational machining process, the vibrational amplitude and frequency of the cutting tool were adjusted to drive the tool tip in an elliptical or linear motion in the feed direction. Furthermore, a finite element analysis was deployed to investigate the mechanical response for different vibration-assisted cutting conditions. The results show how the specific cutting energy and the material's machinability behave when using different operational cutting parameters, such as vibration frequency and tool tip motion in the x-axis, y-axis, and elliptical (x-y plane) motion. Then, the specific cutting energy and material's machinability are compared with a conventional turning process, which helps to validate the finite element method (FEM) for the vibration-assisted process. As a result of the operating parameters used, the vibration-assisted machining process leads to a machinability improvement of up to 18% in S235 carbon steel. In particular, higher vibration frequencies were shown to increase the material's machinability due to the specific cutting energy decrease. Therefore, the finite element method can be used to predict the vibration-assisted cutting and the specific cutting energy, based on predefined cutting parameters.

10.
Rev Colomb Obstet Ginecol ; 70(1): 8-18, 2019 03.
Artículo en Inglés | MEDLINE | ID: mdl-31613066

RESUMEN

OBJETIVE: To identify the causes of maternal mor- tality in the Callao Region between 2000 and 2015. METHODS: Case series study conducted in public and private healthcare institutions in the region of Callao in Perú. Overall, 131 women who met the selection criteria were included as cases of maternal mortality (MM). MM was defined as death of a woman during pregnancy, childbirth or the postpartum period (within the first 42 days after childbirth) in healthcare institutions in Callao. MM clinical-epidemiological records were reviewed. The analysis was performed using percent frequencies and means. RESULTS: Of the causes of MM, 61.1 % were direct and 38.9 % were indirect. The most frequent direct causes were hypertensive disorders of pregnancy, obstetric bleeding and miscarriage. Average time between the onset of discomfort and the decision to ask for assistance was 20 minutes; mean time to arrive at the healthcare institution after making the decision was 20 minutes; and mean delay time between arrival to the institution and provision of care was 7 minutes. Of the total number of maternal deaths, 96.9 % occurred in a healthcare institution. CONCLUSION: The study showed that the causes of MM are mainly of a direct type, primarily due to hypertensive disorders of pregnancy, obstetric bleeding and miscarriage, while indirect causes of MM were less frequent, consisting mainly of infectious causes..


TITULO: CAUSAS DE MUERTE MATERNA EN LA REGIÓN DE CALLAO, PERÚ. ESTUDIO DESCRIPTIVO, 2000-2015. OBJETIVO: Identificar las causas de mortalidad ma- terna en la región de Callao, entre los años 2000 y 2015. METODOS: Estudio de serie de casos en establecimientos de salud (ES) públicos y priva- dos de la región de Callao en Perú. Se incluyeron 131 mujeres como casos de muerte materna (MM) que cumplían los criterios de selección. Se consideró MM, mujer fallecida durante el embarazo, parto o posparto (dentro de los 42 días posparto), en ES del Callao. Se revisaron las historias clínico-epi- demiológicas de MM. El análisis se realizó usando frecuencias porcentuales y promedios. RESULTADOS: El 61,1 % de las causas fueron directas y el 38,9 % indirectas. Las causas directas más frecuentes fueron los trastornos hipertensivos del embarazo, las hemorragias obstétricas y el aborto. La mediana del tiempo que tardó la gestante desde el inicio de las molestias hasta que decidió pedir atención fueron 20 minutos, la mediana del tiempo que tardó en llegar al ES luego de decidir la atención fue de 20 minutos, y la mediana del tiempo de demora desde que llegó la gestante al ES hasta ser atendida fue de 7 minutos. El 96,9 % de las muertes maternas se produjeron en ES. CONCLUSIONES: El estudio demostró que la principal causa de MM es la directa, principalmente debido a trastornos hipertensivos del embarazo; la hemo- rragia obstétrica y el aborto, mientras que en menor proporción fueron las MM indirectas, principal- mente enfermedades infecciosas.


Asunto(s)
Causas de Muerte , Muerte Materna/estadística & datos numéricos , Mortalidad Materna , Complicaciones del Embarazo/mortalidad , Aborto Espontáneo/epidemiología , Aborto Espontáneo/mortalidad , Adolescente , Adulto , Femenino , Humanos , Perú/epidemiología , Hemorragia Posparto/epidemiología , Hemorragia Posparto/mortalidad , Embarazo , Complicaciones del Embarazo/epidemiología , Tiempo de Tratamiento , Adulto Joven
11.
Rev. colomb. obstet. ginecol ; 70(1): 8-18, Jan-Mar. 2019. tab, graf
Artículo en Inglés | LILACS | ID: biblio-1042824

RESUMEN

ABSTRACT Objective: To identify the causes of maternal mortality in the Callao Region between 2000 and 2015. Materials and methods: Case series study conducted in public and private healthcare institutions in the region of Callao in Perú. Overall, 131 women who met the selection criteria were included as cases of maternal mortality (MM). MM was defined as death of a woman during pregnancy, childbirth or the postpartum period (within the first 42 days after childbirth) in healthcare institutions in Callao. MM clinical-epidemiological records were reviewed. The analysis was performed using percent frequencies and means. Results: Of the causes of MM, 61.1 % were direct and 38.9 % were indirect. The most frequent direct causes were hypertensive disorders of pregnancy, obstetric bleeding and miscarriage. Average time between the onset of discomfort and the decision to ask for assistance was 20 minutes; mean time to arrive at the healthcare institution after making the decision was 20 minutes; and mean delay time between arrival to the institution and provision of care was 7 minutes. Of the total number of maternal deaths, 96.9 % occurred in a healthcare institution. Conclusion: The study showed that the causes of MM are mainly of a direct type, primarily due to hypertensive disorders of pregnancy, obstetric bleeding and miscarriage, while indirect causes of MM were less frequent, consisting mainly of infectious causes.


RESUMEN Objetivo: identificar las causas de mortalidad materna en la región de Callao, entre los años 2000 y 2015. Materiales y métodos: estudio de serie de casos en establecimientos de salud (ES) públicos y privados de la región de Callao en Perú. Se incluyeron 131 mujeres como casos de muerte materna (MM) que cumplían los criterios de selección. Se consideró MM, mujer fallecida durante el embarazo, parto o posparto (dentro de los 42 días posparto), en ES del Callao. Se revisaron las historias clínico-epidemiológicas de MM. El análisis se realizó usando frecuencias porcentuales y promedios. Resultados: el 61,1 % de las causas fueron directas y el 38,9 % indirectas. Las causas directas más frecuentes fueron los trastornos hipertensivos del embarazo, las hemorragias obstétricas y el aborto. La mediana del tiempo que tardó la gestante desde el inicio de las molestias hasta que decidió pedir atención fueron 20 minutos, la mediana del tiempo que tardó en llegar al ES luego de decidir la atención fue de 20 minutos, y la mediana del tiempo de demora desde que llegó la gestante al ES hasta ser atendida fue de 7 minutos. El 96,9 % de las muertes maternas se produjeron en ES. Conclusión: el estudio demostró que la principal causa de MM es la directa, principalmente debido a trastornos hipertensivos del embarazo; la hemorragia obstétrica y el aborto, mientras que en menor proporción fueron las MM indirectas, principalmente enfermedades infecciosas.


Asunto(s)
Femenino , Embarazo , Mortalidad Materna , Perú , Embarazo , Epidemiología , Epidemiología Descriptiva , Causalidad
12.
Rev Med Chil ; 146(7): 869-875, 2018 Jul.
Artículo en Español | MEDLINE | ID: mdl-30534886

RESUMEN

BACKGROUND: Multiple myeloma (MM) is one of the most common malignancies found in hematology. AIM: To describe the features of patients with MM and perform a survival analysis according to the different treatment protocols used between 2000 and 2016. MATERIAL AND METHODS: Analysis of the database of the Chilean national anti-neoplastic drug program. Information was obtained from 1,103 patients, with a median age of 64.5 years (range 27-95) and a male to female ratio of 1:1.2. RESULTS: The mean overall survival (OS) of patients receiving or not receiving Thalidomide was 46 and 30 months, respectively (p < 0.01). The mean OS of patients treated before 2007 (treated with melphalan and prednisone) and between 2007 and 2012 (treated with thalidomide and dexamethasone) was 36 and 48 months respectively. In the group starting in 2013 (treated with cyclophosphamide, thalidomide and dexamethasone) the median survival had not been reached at 20 months of follow up (p = 0.01 for all comparisons). Autologous transplantation (AT) was carried out in only 18% of the eligible patients. The median OS of the patients who receive an AT had not been reached at 48 month compared with 36 month among those who did not received the procedure (p < 0.01). CONCLUSIONS: Even though overall survival has improved with time, new drugs must be introduced in our protocols to obtain similar results to those obtained worldwide.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Mieloma Múltiple/tratamiento farmacológico , Adulto , Anciano , Anciano de 80 o más Años , Protocolos de Quimioterapia Combinada Antineoplásica/clasificación , Chile/epidemiología , Supervivencia sin Enfermedad , Femenino , Humanos , Masculino , Persona de Mediana Edad , Mieloma Múltiple/mortalidad , Estudios Retrospectivos , Análisis de Supervivencia
13.
Rev Salud Publica (Bogota) ; 20(1): 67-72, 2018.
Artículo en Español | MEDLINE | ID: mdl-30183887

RESUMEN

OBJECTIVE: To evaluate the effectiveness of mobile technology in the appropriate weight gain of pregnant women. MATERIALS AND METHODS: A quasi-experimental study. The sample included 117 pregnant women attending health facilities at la Dirección Regional de Salud (Diresa), Callao. Messages were sent to 58 pregnant women who formed the experimental group to improve their lifestyles and assistance to prenatal care (APC), while 59 pregnant women received routine education provided for pregnants. Messages were sent every three days. The nutritional status of the pregnant women was evaluated using the pre gestational BMI at the first visit of the APC. The weight gain was obtained from the difference between pre-gestational weight and weight recorded during the last controls. RESULTS: The adequate weight gain was 27.6% of intervened pregnancies and 25.4% in the non-intervened. The 79.3% pregnant had six or more NPC in the group intervened and 54.2% in the non-intervened. The weight gain was excessive in 5.1% in the non-intervened pregnant and 1.7% in the intervened. The highest percentage of pregnant women with adequate weight gain (32.0%) was observed in the intervened pregnancies with pre-gestacional overwhegith. CONCLUSIONS: There was no statistic difference in the use of mobile technology for a proper weight gain between both study groups. There were greater fulfillment of APC in intervened pregnancies compared to the non-intervened (p<0.05).


OBJETIVO: Evaluar la eficacia de la tecnología móvil en la ganancia adecuada de peso de las gestantes estudiadas. MATERIALES Y MÉTODOS: Estudio cuasi-experimental. Se incluyó a 117 gestantes que acudieron a establecimientos de salud de la Dirección Regional de Salud (Diresa), Callao. Se envió mensajes a 58 gestantes que conformaban el grupo experimental para mejorar sus estilos de vida y asistencia al control prenatal (CPN), mientras que 59 gestantes recibieron la educación rutinaria durante la gestación. Los mensajes se enviaron cada tres días. En la primera visita del control pre natal se evaluó el estado nutricional de las gestantes tomando como referencia el IMC pre gestacional. La ganancia de peso se obtuvo por diferencia entre el peso pre-gestacional y peso registrado durante los últimos controles. RESULTADOS: La ganancia de peso adecuada fue 27,6% de gestantes intervenidas y 25,4% en las no intervenidas. El 79,3% de gestantes tuvieron seis o más CPN en el grupo intervenido y 54,2% en las no intervenidas. La ganancia de peso fue excesiva en 5,1% en las gestantes no intervenidas y solo 1,7% en las intervenidas. El mayor porcentaje de gestantes con ganancia de peso adecuada (32,0%) se observó en las gestantes intervenidas con sobrepeso pre gestacional. CONCLUSIONES: No hubo diferencia estadística al usar la tecnología móvil para la adecuada ganancia de peso entre los grupos de estudio. Existió mayor cumplimiento de asistencia al CPN en el grupo de gestantes intervenidas comparado con el no intervenido (p<0,05).


Asunto(s)
Teléfono Celular , Promoción de la Salud/métodos , Aplicaciones Móviles , Atención Prenatal/métodos , Telemedicina/métodos , Aumento de Peso , Adolescente , Adulto , Femenino , Conductas Relacionadas con la Salud , Estilo de Vida Saludable , Humanos , Evaluación de Resultado en la Atención de Salud , Perú , Embarazo , Adulto Joven
14.
Rev. méd. Chile ; 146(7): 869-875, jul. 2018. tab, graf
Artículo en Español | LILACS | ID: biblio-961473

RESUMEN

Background: Multiple myeloma (MM) is one of the most common malignancies found in hematology. Aim: To describe the features of patients with MM and perform a survival analysis according to the different treatment protocols used between 2000 and 2016. Material and Methods: Analysis of the database of the Chilean national anti-neoplastic drug program. Information was obtained from 1,103 patients, with a median age of 64.5 years (range 27-95) and a male to female ratio of 1:1.2. Results: The mean overall survival (OS) of patients receiving or not receiving Thalidomide was 46 and 30 months, respectively (p < 0.01). The mean OS of patients treated before 2007 (treated with melphalan and prednisone) and between 2007 and 2012 (treated with thalidomide and dexamethasone) was 36 and 48 months respectively. In the group starting in 2013 (treated with cyclophosphamide, thalidomide and dexamethasone) the median survival had not been reached at 20 months of follow up (p = 0.01 for all comparisons). Autologous transplantation (AT) was carried out in only 18% of the eligible patients. The median OS of the patients who receive an AT had not been reached at 48 month compared with 36 month among those who did not received the procedure (p < 0.01). Conclusions: Even though overall survival has improved with time, new drugs must be introduced in our protocols to obtain similar results to those obtained worldwide.


Asunto(s)
Humanos , Masculino , Femenino , Adulto , Persona de Mediana Edad , Anciano , Anciano de 80 o más Años , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Mieloma Múltiple/tratamiento farmacológico , Protocolos de Quimioterapia Combinada Antineoplásica/clasificación , Análisis de Supervivencia , Chile/epidemiología , Estudios Retrospectivos , Supervivencia sin Enfermedad , Mieloma Múltiple/mortalidad
15.
Rev Peru Med Exp Salud Publica ; 35(1): 118-125, 2018.
Artículo en Español | MEDLINE | ID: mdl-29924257

RESUMEN

The important benefits of antimicrobial agents in disease control have turned them into a fundamental tool in animal production. Nevertheless, its elevated use and, often, misuse, has contributed to one of the main public health problems in the world: resistance to antimicrobial agents. At the animal production level, the applications in terms of health management allow decreasing the need to use antimicrobial agents and, in the cases where they are needed, the good practices reduce their potential to cause resistance to a minimum. Despite this, the application and development of new strategies that allow facing the problem on a trans-sectoral basis are required, integrating all participants in the public and private sector.


Los importantes beneficios de los antimicrobianos en el control de enfermedades los han transformado en una herramienta fundamental en la producción animal. Sin embargo, su elevado uso y, muchas veces, mal uso, ha contribuido a uno de los principales problemas de la salud pública a nivel mundial: la resistencia a los antimicrobianos. A nivel de la producción animal, las aplicaciones de manejos sanitarios permiten disminuir la necesidad de uso de antimicrobianos y en caso de necesitar su utilización, las buenas prácticas reducen al mínimo la posibilidad de generar resistencia. A pesar de esto, es necesario la aplicación y el desarrollo de nuevas estrategias que permitan enfrentar el problema de manera intersectorial, integrando a todos los participantes del sector público y privado.


Asunto(s)
Acuicultura , Farmacorresistencia Microbiana , Industria de Alimentos , Productos de la Carne , Salud Pública , Animales , Humanos
16.
Rev. peru. med. exp. salud publica ; 35(1): 118-125, ene.-mar. 2018. ilus, tab
Artículo en Español | LILACS | ID: biblio-1043264

RESUMEN

Los importantes beneficios de los antimicrobianos en el control de enfermedades los han transformado en una herramienta fundamental en la producción animal. Sin embargo, su elevado uso y, muchas veces, mal uso, ha contribuido a uno de los principales problemas de la salud pública a nivel mundial: la resistencia a los antimicrobianos. A nivel de la producción animal, las aplicaciones de manejos sanitarios permiten disminuir la necesidad de uso de antimicrobianos y en caso de necesitar su utilización, las buenas prácticas reducen al mínimo la posibilidad de generar resistencia. A pesar de esto, es necesario la aplicación y el desarrollo de nuevas estrategias que permitan enfrentar el problema de manera intersectorial, integrando a todos los participantes del sector público y privado.


The important benefits of antimicrobial agents in disease control have turned them into a fundamental tool in animal production. Nevertheless, its elevated use and, often, misuse, has contributed to one of the main public health problems in the world: resistance to antimicrobial agents. At the animal production level, the applications in terms of health management allow decreasing the need to use antimicrobial agents and, in the cases where they are needed, the good practices reduce their potential to cause resistance to a minimum. Despite this, the application and development of new strategies that allow facing the problem on a trans-sectoral basis are required, integrating all participants in the public and private sector.


Asunto(s)
Animales , Humanos , Farmacorresistencia Microbiana , Industria de Alimentos , Salud Pública , Acuicultura , Productos de la Carne
17.
Rev. salud pública ; Rev. salud pública;20(1): 67-72, ene.-feb. 2018. tab
Artículo en Español | LILACS | ID: biblio-962094

RESUMEN

RESUMEN Objetivo Evaluar la eficacia de la tecnología móvil en la ganancia adecuada de peso de las gestantes estudiadas. Materiales y Métodos Estudio cuasi-experimental. Se incluyó a 117 gestantes que acudieron a establecimientos de salud de la Dirección Regional de Salud (Diresa), Callao. Se envió mensajes a 58 gestantes que conformaban el grupo experimental para mejorar sus estilos de vida y asistencia al control prenatal (CPN), mientras que 59 gestantes recibieron la educación rutinaria durante la gestación. Los mensajes se enviaron cada tres días. En la primera visita del control pre natal se evaluó el estado nutricional de las gestantes tomando como referencia el IMC pre gestacional. La ganancia de peso se obtuvo por diferencia entre el peso pre-gestacional y peso registrado durante los últimos controles. Resultados La ganancia de peso adecuada fue 27,6% de gestantes intervenidas y 25,4% en las no intervenidas. El 79,3% de gestantes tuvieron seis o más CPN en el grupo intervenido y 54,2% en las no intervenidas. La ganancia de peso fue excesiva en 5,1% en las gestantes no intervenidas y solo 1,7% en las intervenidas. El mayor porcentaje de gestantes con ganancia de peso adecuada (32,0%) se observó en las gestantes intervenidas con sobrepeso pre gestacional. Conclusiones No hubo diferencia estadística al usar la tecnología móvil para la adecuada ganancia de peso entre los grupos de estudio. Existió mayor cumplimiento de asistencia al CPN en el grupo de gestantes intervenidas comparado con el no intervenido (p<0,05).(AU)


ABSTRACT Objective To evaluate the effectiveness of mobile technology in the appropriate weight gain of pregnant women. Materials and Methods A quasi-experimental study. The sample included 117 pregnant women attending health facilities at la Dirección Regional de Salud (Diresa), Callao. Messages were sent to 58 pregnant women who formed the experimental group to improve their lifestyles and assistance to prenatal care (APC), while 59 pregnant women received routine education provided for pregnants. Messages were sent every three days. The nutritional status of the pregnant women was evaluated using the pre gestational BMI at the first visit of the APC. The weight gain was obtained from the difference between pre-gestational weight and weight recorded during the last controls. Results The adequate weight gain was 27.6% of intervened pregnancies and 25.4% in the non-intervened. The 79.3% pregnant had six or more NPC in the group intervened and 54.2% in the non-intervened. The weight gain was excessive in 5.1% in the non-intervened pregnant and 1.7% in the intervened. The highest percentage of pregnant women with adequate weight gain (32.0%) was observed in the intervened pregnancies with pre-gestacional overwhegith. Conclusions There was no statistic difference in the use of mobile technology for a proper weight gain between both study groups. There were greater fulfillment of APC in intervened pregnancies compared to the non-intervened (p<0.05).(AU)


Asunto(s)
Humanos , Femenino , Embarazo , Atención Prenatal/métodos , Obesidad Materna/epidemiología , Perú/epidemiología , Teléfono Celular/instrumentación , Ensayos Clínicos Controlados no Aleatorios como Asunto
18.
Rev Panam Salud Publica ; 41: e49, 2017 May 25.
Artículo en Español | MEDLINE | ID: mdl-28591335

RESUMEN

OBJECTIVE: Determine the acceptability, perceived usefulness, and adoption of implementation tools and technical assistance provided by the Health Technology Assessment Institute (IETS) in hospitals in two regions of Colombia. METHODS: Assistance was provided for implementation of clinical practice guidelines (CPGs) in 24 hospitals (17 in Antioquia and seven in Cundinamarca) in areas with high prevalence of sexually transmitted infections, and for use of the implementation tools. Health professionals were given surveys and medical specialists were interviewed. RESULTS: Overall, 86% of respondents are familiar with the GPGs, 86% with the tracer recommendations, 79% with the interactive flow charts, and 82% with the evidence sheets, while 41% never used the implementation tools. Of the respondents who used the tools, 55% did so on their work computer, while 24% used their personal telephone. The most useful tools were the evidence sheets and flow charts (98%) and the tracer recommendations (92%). The least useful were the budgetary impact tools (81%). CONCLUSIONS: The implementation tools and technical assistance provided in hospitals in two regions of Colombia are perceived as useful and acceptable, although the degree of implementation is low. The findings of this research will help the different actors, such as the Ministry of Health and Social Protection, the IETS, and the Administrative Department of Science, Technology and Innovation (Colciencias), among others, improve their programs for the implementation of clinical practice guidelines.


Asunto(s)
Adhesión a Directriz/estadística & datos numéricos , Enfermedades de Transmisión Sexual/terapia , Colombia , Humanos
19.
Artículo en Español | PAHO-IRIS | ID: phr-34035

RESUMEN

Objetivo. Establecer la aceptabilidad, percepción de utilidad y la implantación de las herramientas de implementación y el acompañamiento técnico del Instituto de Evaluación Tecnológica en Salud (IETS) en los hospitales de dos regiones de Colombia. Métodos. Se desarrolló acompañamiento para la implementación de la Guía de Práctica Clínica (GPC) en 24 hospitales (17 de Antioquía y 7 de Cundinamarca) en zonas de alta prevalencia de infecciones de transmisión sexual (ITS), así como la instalación de las herramientas de implementación. Se aplicaron encuestas a los profesionales y entrevistas a los referentes. Resultados. Del total de los encuestados, 86% conocen la GPC, 86% las recomendaciones trazadoras, 79% los flujogramas interactivos, 82% las hojas de evidencia y 41% nunca utilizó las herramientas de implementación. De los encuestados que han utilizado las herramientas, 55% lo hacen en el ordenador del sitio de trabajo, mientras que 24% utiliza su teléfono personal. Las herramientas de mayor utilidad son las hojas de evidencia y los flujogramas con 98% y las recomendaciones trazadoras con 92%. Las de más baja utilidad son las herramientas de impacto presupuestal (81%). Conclusiones. Las herramientas de implementación y el acompañamiento técnico en los hospitales de dos regiones de Colombia se perciben como útiles y aceptables, aunque el grado de implantación es bajo. Los hallazgos de esta investigación contribuirán para que los diferentes actores, como el Ministerio de Salud y Protección Social, el IETS y el Departamento Administrativo de Ciencia, Tecnología e Innovación (Colciencias) entre otros, puedan mejorar los programas de implementación de guías de práctica clínica.


Objective. Determine the acceptability, perceived usefulness, and adoption of implementation tools and technical assistance provided by the Health Technology Assessment Institute (IETS) in hospitals in two regions of Colombia. Methods. Assistance was provided for implementation of clinical practice guidelines (CPGs) in 24 hospitals (17 in Antioquia and seven in Cundinamarca) in areas with high prevalence of sexually transmitted infections, and for use of the implementation tools. Health professionals were given surveys and medical specialists were interviewed. Results. Overall, 86% of respondents are familiar with the GPGs, 86% with the tracer recommendations, 79% with the interactive flow charts, and 82% with the evidence sheets, while 41% never used the implementation tools. Of the respondents who used the tools, 55% did so on their work computer, while 24% used their personal telephone. The most useful tools were the evidence sheets and flow charts (98%) and the tracer recommendations (92%). The least useful were the budgetary impact tools (81%). Conclusions. The implementation tools and technical assistance provided in hospitals in two regions of Colombia are perceived as useful and acceptable, although the degree of implementation is low. The findings of this research will help the different actors, such as the Ministry of Health and Social Protection, the IETS, and the Administrative Department of Science, Technology and Innovation (Colciencias), among others, improve their programs for the implementation of clinical practice guidelines.


Asunto(s)
Implementación de Plan de Salud , Guía de Práctica Clínica , Guía de Práctica Clínica , Enfermedades de Transmisión Sexual , Implementación de Plan de Salud
20.
Rev. panam. salud pública ; 41: e49, 2017. graf
Artículo en Español | LILACS | ID: biblio-845683

RESUMEN

RESUMEN Objetivo Establecer la aceptabilidad, percepción de utilidad y la implantación de las herramientas de implementación y el acompañamiento técnico del Instituto de Evaluación Tecnológica en Salud (IETS) en los hospitales de dos regiones de Colombia. Métodos Se desarrolló acompañamiento para la implementación de la Guía de Práctica Clínica (GPC) en 24 hospitales (17 de Antioquía y 7 de Cundinamarca) en zonas de alta prevalencia de infecciones de transmisión sexual (ITS), así como la instalación de las herramientas de implementación. Se aplicaron encuestas a los profesionales y entrevistas a los referentes. Resultados Del total de los encuestados, 86% conocen la GPC, 86% las recomendaciones trazadoras, 79% los flujogramas interactivos, 82% las hojas de evidencia y 41% nunca utilizó las herramientas de implementación. De los encuestados que han utilizado las herramientas, 55% lo hacen en el ordenador del sitio de trabajo, mientras que 24% utiliza su teléfono personal. Las herramientas de mayor utilidad son las hojas de evidencia y los flujogramas con 98% y las recomendaciones trazadoras con 92%. Las de más baja utilidad son las herramientas de impacto presupuestal (81%). Conclusiones Las herramientas de implementación y el acompañamiento técnico en los hospitales de dos regiones de Colombia se perciben como útiles y aceptables, aunque el grado de implantación es bajo. Los hallazgos de esta investigación contribuirán para que los diferentes actores, como el Ministerio de Salud y Protección Social, el IETS y el Departamento Administrativo de Ciencia, Tecnología e Innovación (Colciencias) entre otros, puedan mejorar los programas de implementación de guías de práctica clínica.


ABSTRACT Objective Determine the acceptability, perceived usefulness, and adoption of implementation tools and technical assistance provided by the Health Technology Assessment Institute (IETS) in hospitals in two regions of Colombia. Methods Assistance was provided for implementation of clinical practice guidelines (CPGs) in 24 hospitals (17 in Antioquia and seven in Cundinamarca) in areas with high prevalence of sexually transmitted infections, and for use of the implementation tools. Health professionals were given surveys and medical specialists were interviewed. Results Overall, 86% of respondents are familiar with the GPGs, 86% with the tracer recommendations, 79% with the interactive flow charts, and 82% with the evidence sheets, while 41% never used the implementation tools. Of the respondents who used the tools, 55% did so on their work computer, while 24% used their personal telephone. The most useful tools were the evidence sheets and flow charts (98%) and the tracer recommendations (92%). The least useful were the budgetary impact tools (81%). Conclusions The implementation tools and technical assistance provided in hospitals in two regions of Colombia are perceived as useful and acceptable, although the degree of implementation is low. The findings of this research will help the different actors, such as the Ministry of Health and Social Protection, the IETS, and the Administrative Department of Science, Technology and Innovation (Colciencias), among others, improve their programs for the implementation of clinical practice guidelines.


Asunto(s)
Enfermedades de Transmisión Sexual/terapia , Enfermedades de Transmisión Sexual/transmisión , Adhesión a Directriz/estadística & datos numéricos , Colombia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA